Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Eur J Contracept Reprod Health Care ; 26(4): 326-333, 2021 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-33871288

RESUMO

OBJECTIVES: The Contraceptive Counselling (COCO) study tested whether a structured approach to assessing patient needs and expectations improved method choice and satisfaction with the contraceptive decision-making process. METHODS: Physicians and women were invited to complete needs-based contraceptive counselling sessions using a structured questionnaire. Physicians recorded the individual responses online; women evaluated the process using an immediate post-consultation questionnaire and then via a structured online interview 6 months later. RESULTS: A total of 92 gynaecologists and 1176 women participated: 951 women completed the immediate post-consultation survey and 145 took part in the 6 month online evaluation. There was a substantial increase in satisfaction with the current contraceptive method: the number of women reporting they were 'very satisfied' with their contraceptive method increased by 30%. This applied to starters and switchers as well as to women continuing with their previous method. Women were highly satisfied with the structured approach; 95% rated the counselling as 'good' or 'very good' and 'comprehensive and detailed'. CONCLUSION: Using a structured approach to share information tailored to women's needs can help them choose from a broader range of methods and, in some cases, change to a method more suitable to their individual needs, and ultimately increase satisfaction with their choice.


Assuntos
Anticoncepção , Aconselhamento/métodos , Tomada de Decisão Compartilhada , Participação do Paciente , Assistência Centrada no Paciente , Médicos/psicologia , Adulto , Anticoncepcionais , Dispositivos Anticoncepcionais , Tomada de Decisões , Feminino , Ginecologia , Humanos , Pessoa de Meia-Idade , Preferência do Paciente
2.
Physiol Biochem Zool ; 83(5): 733-52, 2010.
Artigo em Inglês | MEDLINE | ID: mdl-20565233

RESUMO

Many invertebrates and ectothermic vertebrates successfully cope with a fluctuating supply of ambient oxygen-and consequently, a highly variable tissue oxygenation-through increasing their antioxidant barriers. During chronic deprivation of oxygen, however, the hypometabolic defense mode of the fruit fly Drosophila, the hypoxia-induced behavioral hypothermia of the crayfish Pacifastacus leniusculus, and the production of ethanol during anoxia by the crucian carp Carassius carassius all indicate that these animals are also capable of utilizing a suite of genetic and physiological defenses to survive otherwise lethal reductions in tissue oxygenation. Normally, much of an organism's gene response to hypoxia is orchestrated via the hypoxia-inducible transcription factor HIF. Recent developments expand our view of HIF function even further by highlighting regulatory roles for HIF in the hypometabolism of insects, in the molting and the normoxic immune response of crustaceans, and in the control-via the downstream effector gene erythropoietin-of the hypoxic ventilatory response and pulmonary hypertension in mammals. These and related topics were collectively presented by the authors in a symposium of the 2008 ICA-CBP conference at Mara National Reserve, Kenya, Africa. This synthesis article communicates the essence of the symposium presentations to the wider community.


Assuntos
Adaptação Fisiológica/fisiologia , Fator 1 Induzível por Hipóxia/metabolismo , Hipóxia/fisiopatologia , Estresse Oxidativo/fisiologia , Oxigênio/metabolismo , Animais , Metabolismo Energético/fisiologia , Imunidade Inata/fisiologia , Ventilação Pulmonar/fisiologia , Especificidade da Espécie , Temperatura
3.
Gen Physiol Biophys ; 27(2): 127-42, 2008 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-18645228

RESUMO

S100A1 is a Ca(2+)-binding protein and predominantly expressed in the heart. We have generated a mouse line of S100A1 deficiency by gene trap mutagenesis to investigate the impact of S100A1 ablation on heart function. Electrocardiogram recordings revealed that after beta-adrenergic stimulation S100A1-deficient mice had prolonged QT, QTc and ST intervals and intraventricular conduction disturbances reminiscent of 2 : 1 bundle branch block. In order to identify genes affected by the loss of S100A1, we profiled the mutant and wild type cardiac transcriptomes by gene array analysis. The expression of several genes functioning to the electrical activity of the heart were found to be significantly altered. Although the default prediction would be that mRNA and protein levels are highly correlated, comprehensive immunoblot analyses of salient up- or down-regulated candidate genes of any cellular network revealed no significant changes on protein level. Taken together, we found that S100A1 deficiency results in cardiac repolarization delay and alternating ventricular conduction defects in response to sympathetic activation accompanied by a significantly different transcriptional regulation.


Assuntos
Agonistas Adrenérgicos beta/farmacologia , Coração/fisiologia , Proteínas S100/fisiologia , Agonistas alfa-Adrenérgicos/farmacologia , Animais , Dobutamina/farmacologia , Eletrocardiografia , Perfilação da Expressão Gênica , Sistema de Condução Cardíaco/efeitos dos fármacos , Isoproterenol/farmacologia , Camundongos , Camundongos Knockout , Miocárdio/metabolismo , Norepinefrina/farmacologia , Análise de Sequência com Séries de Oligonucleotídeos , Proteínas S100/genética , Função Ventricular Esquerda/efeitos dos fármacos , Pressão Ventricular/efeitos dos fármacos
4.
Pflugers Arch ; 446(4): 437-46, 2003 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-12733076

RESUMO

Continuous i.v. infusion of norepinephrine in rats has been shown to induce early interleukin (IL)-6 mRNA expression in the left ventricle (LV) which was followed by hypertrophy and fibrosis. In this study, two approaches were used. In the first, NE (0.1 mg/kg per hour) was infused i.v. in rats for several time periods, and freshly obtained ventricular myocardium was dissociated into myocyte (MC) and non-myocyte (NMC) fractions. Second, isolated adult MCs and fibroblasts were treated with NE (10 microM). NE infusion (4 h, in vivo) caused an 11-fold increase in IL-6 mRNA in both cell populations. In vitro treatment of isolated adult MCs for 2 h and of fibroblasts for 1 h with NE induced a 3.5- and 23-fold maximum increase, respectively, in IL-6 mRNA. After in vivo NE treatment, the expression of the mRNA of the transcriptional factor of IL-6, C/EBP-beta, was elevated earlier (after 45 min of NE infusion) than IL-6 mRNA (after 4 h) and was seen in MCs and NMCs. The mRNAs of both receptors of IL-6, the soluble IL6R and gp130, were increased subsequently to IL-6 mRNA. Gp130 was elevated after 24 h and, like IL6R, predominantly in NMCs. In contrast, the IL6R protein and the downstream regulator STAT3 were increased only in MCs after 24 h of NE infusion. The mRNA of C/EBP-delta, which is regulated by STAT3, was elevated only in myocytes.


Assuntos
Agonistas alfa-Adrenérgicos/farmacologia , Interleucina-6/genética , Miócitos Cardíacos/fisiologia , Norepinefrina/farmacologia , Transdução de Sinais/efeitos dos fármacos , Animais , Antígenos CD/genética , Proteínas Estimuladoras de Ligação a CCAAT/genética , Proteínas Estimuladoras de Ligação a CCAAT/metabolismo , Receptor gp130 de Citocina , Proteínas de Ligação a DNA/metabolismo , Feminino , Fibroblastos/fisiologia , Expressão Gênica/efeitos dos fármacos , Interleucina-6/metabolismo , Glicoproteínas de Membrana/genética , Fosforilação , RNA Mensageiro/análise , Ratos , Ratos Sprague-Dawley , Receptores de Interleucina-6/genética , Receptores de Interleucina-6/metabolismo , Fator de Transcrição STAT3 , Transativadores/metabolismo
5.
Cardiovasc Res ; 52(2): 265-73, 2001 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-11684074

RESUMO

OBJECTIVE: In this study we have tested the hypothesis that degradation of collagen by matrix metalloproteinase 2 (MMP-2) precedes the deposition of extracellular matrix (ECM) after long term norepinephrine (NE) treatment. METHODS: Female Sprague-Dawley rats received continuous i.v. infusion of NE (0.1 mg/kg.h) for 1, 2, 3, 4 and 14 days. Heart function and weight as well as expression of cardiac colligin and of collagen I and III were examined. Furthermore, we have assessed the degradation pathway of collagen by measuring the mRNA and activity of myocardial MMP-2 and tissue inhibitor of metalloproteinase 2 (TIMP-2) as well as the protein level of TIMP-2. RESULTS: NE induced hypertrophy predominantly of the left ventricle (LV) in a time-dependent manner. It increased the mRNAs of colligin, collagen I and III, and of MMP-2 and TIMP-2 as well as MMP-2 activity in two phases: In the initial phase, at 3 and 4 days, the mRNA of colligin and of collagen I and III was elevated predominantly in the LV, MMP-2 and TIMP-2 mRNA, as well as TIMP-2 protein and MMP-activity were increased in both ventricles. The second phase, after 14 days, was characterized by a less pronounced increase in colligin, collagen I and III and in MMP-2 activity which occurred exclusively in the LV. Finally, long-term treatment with NE induced a 37% increase in interstitial fibrosis which was shown to occur exclusively in the LV after 14 days. CONCLUSION: NE treatment induced fibrosis exclusively in the LV which was associated with hypertrophy predominantly of the LV. The elevated MMP-2 activity seems to be necessary for the ECM to adapt to the enlargement of myocytes and to reduce overproduction of collagen.


Assuntos
Matriz Extracelular/metabolismo , Hipertrofia Ventricular Esquerda/metabolismo , Metaloproteinase 2 da Matriz/metabolismo , Miocárdio/metabolismo , Norepinefrina/farmacologia , Inibidor Tecidual de Metaloproteinase-2/metabolismo , Antagonistas Adrenérgicos/farmacologia , Análise de Variância , Animais , Western Blotting , Bloqueadores dos Canais de Cálcio/farmacologia , Carbazóis/farmacologia , Carvedilol , Colágeno Tipo I/metabolismo , Colágeno Tipo III/metabolismo , Eletroforese em Gel de Poliacrilamida , Feminino , Fibrose , Expressão Gênica/efeitos dos fármacos , Hipertrofia Ventricular Esquerda/patologia , Infusões Intravenosas , Metaloproteinase 2 da Matriz/genética , Nisoldipino/farmacologia , Propanolaminas/farmacologia , RNA Mensageiro/análise , Ratos , Ratos Sprague-Dawley , Fatores de Tempo , Inibidor Tecidual de Metaloproteinase-2/genética , Remodelação Ventricular
6.
J Mol Cell Cardiol ; 33(6): 1191-207, 2001 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-11444923

RESUMO

Extensive myocardial remodeling occurs after transmural myocardial infarction (MI). The infarcted myocardium is being replaced by scar tissue after gradual resorption of the necrotic tissue. The remodeling process involves both synthesis and degradation of collagens as major components of the extracellular matrix (ECM). In the present study we have analyzed the time-dependent changes of the processes related to this fibrosis in the infarct area and in the non-infarcted left ventricle (LV) six hours to 82 days after occlusion of the left anterior descending coronary artery (LAD) in rats. We also examined whether changes occurred in the expression pattern of the transforming growth factor (TGF) beta isoforms, since this cytokine is known as powerful inductor of fibrosis. Elevation in colligin expression preceded the pronounced increase in mRNA expression of both type I and type III collagen after MI from day three onwards. The maximal increase in colligin protein in the infarct area coincided with the most pronounced expression of collagen I and collagen III mRNA expression. Also, the expression and activity of matrix metalloproteinases (MMPs) and of tissue inhibitor of matrix metalloproteinase (TIMP)-2 mRNA were increased predominantly in the infarct area. TGF beta(1)and TGF-beta(2)expression increased within the first days after MI, whereas TGF-beta(3)expression was elevated predominantly in the infarct area. This pronounced increase in TGF-beta(3)persisted up to 82 days and correlated positively with the parameters of ECM metabolism. Thus, the scar formation is an ongoing dynamic process in which TGF-beta(3)seems to play an active role in the complex ventricular remodeling.


Assuntos
Matriz Extracelular/metabolismo , Expressão Gênica , Infarto do Miocárdio/metabolismo , Miocárdio/metabolismo , Fator de Crescimento Transformador beta/genética , Animais , Artérias , Proteínas de Transporte/genética , Proteínas de Transporte/metabolismo , Colágeno/genética , Vasos Coronários , Feminino , Gelatina/metabolismo , Glicoproteínas , Hemodinâmica , Hipertrofia Ventricular Direita/metabolismo , Hipertrofia Ventricular Direita/fisiopatologia , Metaloproteinase 2 da Matriz/genética , Metaloproteinase 2 da Matriz/metabolismo , Metaloproteinase 8 da Matriz/genética , Metaloproteinase 8 da Matriz/metabolismo , Metaloproteinase 9 da Matriz/genética , Metaloproteinase 9 da Matriz/metabolismo , Infarto do Miocárdio/fisiopatologia , Isoformas de Proteínas/genética , RNA Mensageiro , Ratos , Ratos Sprague-Dawley , Inibidor Tecidual de Metaloproteinase-2/genética , Fator de Crescimento Transformador beta1 , Fator de Crescimento Transformador beta2 , Fator de Crescimento Transformador beta3 , Disfunção Ventricular Esquerda/metabolismo , Disfunção Ventricular Esquerda/fisiopatologia , Disfunção Ventricular Direita/metabolismo , Disfunção Ventricular Direita/fisiopatologia
7.
Am J Physiol Heart Circ Physiol ; 281(1): H14-21, 2001 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-11406463

RESUMO

Proinflammatory cytokines have been implicated in the pathophysiology of different heart diseases. Recent evidence suggests that interleukin-6 (IL--6) may play a role in mechanisms leading to cardiac hypertrophy. In addition, catecholamines are known to induce cardiac hypertrophy. In the present study, we examined whether cardiac fibroblasts may be a potential source of IL--6 production in the rat heart and whether catecholamines can modulate the IL--6 synthesis. Only a small amount of IL--6 mRNA was detected in unstimulated rat cardiac fibroblasts. However, a 50-fold increase of IL--6 mRNA was found after stimulation with norepinephrine (NE). Addition of carvedilol, a alpha- and beta-adrenergic receptor antagonist, prevented almost completely the NE-induced synthesis of IL--6 mRNA. Phenylephrine, an alpha-adrenergic agonist, and isoproterenol, a beta-adrenergic agonist, also induced an increase in IL--6. However, the stimulation via beta-receptors led to a more pronounced elevation. These data show that NE increases IL--6 expression in rat cardiac fibroblasts and that IL--6 may play an important autocrine/paracrine role in cardiac disease states associated with hypertrophy.


Assuntos
Fibroblastos/efeitos dos fármacos , Fibroblastos/metabolismo , Interleucina-6/biossíntese , Miocárdio/metabolismo , Norepinefrina/farmacologia , Animais , Células Cultivadas , Citocinas/genética , Feminino , Fibroblastos/fisiologia , Expressão Gênica/efeitos dos fármacos , Interleucina-6/genética , Miocárdio/citologia , RNA Mensageiro/metabolismo , Ratos , Ratos Sprague-Dawley , Receptores Adrenérgicos alfa/fisiologia , Receptores Adrenérgicos beta/fisiologia
8.
J Mol Cell Cardiol ; 32(2): 273-84, 2000 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-10722803

RESUMO

Continuous intravenous infusion of norepinephrine norepinephrine (NE, 0.1 mg/kg/h) induced hypertrophy of the left ventricle (LV), but not of the right ventricle (RV) in rats, although RV systolic pressure (RVSP) was much more elevated than LVSP. After NE infusion, there was a time-dependent (20 min to 72 h) expression in the mRNA of interleukin (IL)-6 and IL-1 beta. The expression of IL-6 increased markedly and reached the maximum after 4 h with an 80-fold elevation. In the RV, the expression increased only 20-fold. The mRNA of IL-1 beta increased significantly after NE stimulation only in the LV and reached the maximum after 12 h with a 12-fold elevation. After 12 h of NE infusion, colligin mRNA was elevated for the first time with further progression until 72 h. The six-fold abundance of colligin mRNA seen after 72 h was significantly higher in the LV than in the RV. A similar increase was observed on the protein level (Western blotting). The expression of collagen I and III increased significantly after 24 h only in the LV. After 72 h, the mRNA expression of collagen I was increased 16-fold and that of collagen III 10-fold. This expression was significantly higher than that in the RV. Also the elevation in atrial natriuretic peptide (ANP) mRNA started earlier and was more pronounced in the LV than in the RV. The alpha- and beta-adrenergic receptor blocker carvedilol normalized all functional parameters after 6 h and 72 h and prevented the development of LV hypertrophy that occurred after 72 h. The NE-induced increased expression of the mRNAs studied was either prevented (IL-6, IL-1 beta ) or attenuated (colligin, collagen I and III, ANP) by combined alpha- and beta-receptor blockade. The elevation of afterload which was associated with the NE effect was normalized by the calcium-channel blocker nisoldipin, but NE-induced LV hypertrophy and the increase in ANP and collagen mRNA were not affected.


Assuntos
Colágeno/biossíntese , Citocinas/biossíntese , Regulação da Expressão Gênica/efeitos dos fármacos , Hipertrofia Ventricular Esquerda/induzido quimicamente , Proteínas Musculares/biossíntese , Norepinefrina/farmacologia , Remodelação Ventricular/efeitos dos fármacos , Antagonistas Adrenérgicos/farmacologia , Animais , Fator Natriurético Atrial/biossíntese , Fator Natriurético Atrial/genética , Bloqueadores dos Canais de Cálcio/farmacologia , Carbazóis/farmacologia , Proteínas de Transporte/biossíntese , Proteínas de Transporte/genética , Carvedilol , Colágeno/genética , Citocinas/genética , Feminino , Glicoproteínas , Hemodinâmica/efeitos dos fármacos , Hipertrofia Ventricular Esquerda/genética , Hipertrofia Ventricular Esquerda/metabolismo , Hipertrofia Ventricular Esquerda/patologia , Interleucina-1/biossíntese , Interleucina-1/genética , Interleucina-6/biossíntese , Interleucina-6/genética , Proteínas Musculares/genética , Nisoldipino/farmacologia , Propanolaminas/farmacologia , Isoformas de Proteínas/biossíntese , Isoformas de Proteínas/genética , RNA Mensageiro/biossíntese , RNA Mensageiro/genética , Ratos , Ratos Sprague-Dawley , Remodelação Ventricular/genética
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...